Objective To observe the clinical effect of syndrome differentiation and treatment on progressive stroke based on the theory of Wei

Qi

Ying and Xue. Methods Totally 120 patients with progressive stroke were divided into a treatment group and a control group

with 60 cases in each. There were 15 cases of Weifen syndrome

15 of Qifen syndrome

15 of Yingfen syndrome

and 15 of Xuefen syndrome in treatment group. Based on the routine treatment of western medicine

those with Weifen syndrome were added with Qufeng Decoction（ 驱风汤）

those with Qifen syndrome were added with Xinglou Chengqi Decoction（ 星蒌承气汤） combined with Yunv Jian Decoction（ 玉女煎）

those with Yingfen syndrome were added with Qingying Decoction（ 清营汤）

and those with Xuefen syndrome were added with Taohe Chengqi Decoction（ 桃核承气汤） or Buyang Huanwu Decoction（ 补阳还五汤）. In the control group

there were 12 cases of liver Yang hyperactivity and wind fire pathogen syndrome

12 of wind phlegm with blood stasis and stagnating collaterals syndrome

12 of phlegm-heat accumulation and wind-phlegm invading upward syndrome

12 of Qi deficiency with blood stagnation syndrome

and 12 of wind formation from Yin deficiency syndrome. Based on the routine western medicine treatment

those with liver Yang hyperactivity and wind fire pathogen syndrome were added with Tianma Gouteng Yin（ 天麻钩藤饮）

those with wind phlegm with blood stasis stagnating collaterals syndrome were added with Huatan Tongluo Decoction（ 化痰通络汤）

those with phlegm-heat accumulation and wind-phlegm invading upward syndrome were added with Xinglou Chengqi Decoction

those with Qi deficiency with blood stagnation syndrome were added with Buyang Huanwu Decoction

and those with wind formation from Yin deficiency syndrome were added with Zhengan Xifeng Decoction（ 镇肝熄风汤） for treatment. National Institute of Health Stroke Scale（ NIHSS） and scale score of Barthe index（ BI） of patients with each syndrome in each group were evaluated before and 30 days and 90 days after treatment respectively. Results NIHSS scores of each syndrome type in both the treatment group and the control group all remarkably decreased

while BI remarkably increased30 days and 90 days after treatment compared with that before treatment（ P < 0. 01）

and the improvement of NIHSS and BI 90 days after treatment were all superior to that 30 days after treatment（ P < 0. 01）. Improvement of NIHSS and BI 30 and 90 days after treatment in the treatment group were all superior to that in the control group（ P <0. 01）. Conclusion Applying syndrome differentiation of Wei

Qi

Ying and Xue to treat patients with progressive stroke can remarkably improve neurologic impairment and activity of daily living. The curative effects were superior to that of the traditional viscera syndrome differentiation.